Challenges in the Discovery of Novel Therapeutic Agents in Cancer (Part III)

Author(s): Mohammad A. Kamal, Ganji P. Nagaraju

Journal Name: Current Drug Metabolism

Volume 21 , Issue 1 , 2020

Become EABM
Become Reviewer
Call for Editor

Rokkam, P.; Gugalavath, S. Deepak Kgk, Vempati RK, Malla RR. Prognostic role of Hedgehog GLI1 ssignaling pathway in aggressive and metastatic breast cancers. Curr. Drug Metab., 2020, 21(1), 33-43.
Mukund, V. Genistein: Its role in breast cancer growth and metastasis. Curr. Drug Metab., 2020, 21(1), 6-10.
Malla, R.R.; Vempati, R.K. Talin: A potential drug target for Cancer therapy. Curr. Drug Metab., 2020, 21(1), 25-32.
Durthi, C.P.; Pola, M.; Rajulapati, S.B.; Kola, A.K.; Kamal, M.A. Versatile and Valuable Utilization of Amidohydrolase L-glutaminase in Pharma and Food industries: A Review. Curr. Drug Metab., 2020, 21(1), 11-24.
Bhaskar, Birru; ChandraSai Potla, Durthi; Santhosh, Kacham; Madhuri, Pola; Satish Babu, Rajulapati; Sreenivasa Rao, Parcha; Mohammad Amjad, Kamal Stem Cells in Tumour Microenvironment Aid in Prolonged Survival Rate of Cancer Cells and Developed Drug Resistance: Major Challenge in Osteosarcoma Treatment. Curr. Drug Metab., 2020, 21(1), 44-52.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [4 - 5]
Pages: 2
DOI: 10.2174/138920022101200429122759

Article Metrics

PDF: 23